 GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2021 GLOBE NEWSWIRE -- Applied Genetic Technologies Corporation Nasdaq: AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus AAV-based gene therapies for the treatment of rare diseases, today announced that Sue Washer, President Chief Executive Officer, will participate at the OIS Gene Therapy Innovation Showcase, taking place virtually on Thursday, February 18, 2021 from 12:00 PM to 3:00 PM CST. 